 MORRISTOWN, N.J., Oct. 25, 2022 GLOBE NEWSWIRE -- Intercept Pharmaceuticals, Inc. Nasdaq: ICPT, a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its third quarter 2022 financial results prior to market open on Tuesday, November 1, 2022. The announcement will be followed by a conference call and audio webcast at 8:30 a.m. ET. 